Drugs 5 years later: procarbazine.
D000818:Animals; D001859:Bone Neoplasms / Q000188:drug therapy; D002273:Carcinogens; D002277:Carcinoma / Q000188:drug therapy; D004341:Drug Evaluation; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D009101:Multiple Myeloma / Q000188:drug therapy; D009196:Myeloproliferative Disorders / Q000188:drug therapy; D009369:Neoplasms / Q000188:drug therapy*; D011087:Polycythemia Vera / Q000188:drug therapy; D011344:Procarbazine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use
D002273:Carcinogens; D011344:Procarbazine